Clinical Trial Detail

NCT ID NCT02289144
Title Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Texas Southwestern Medical Center
Indications

thyroid cancer

Therapies

Ceritinib

Age Groups: adult

Additional content available in CKB BOOST